...
首页> 外文期刊>Bioorganic and Medicinal Chemistry >Functionalised 2,3-dimethyl-3-aminotetrahydrofuran-4-one and N-(3-oxo-hexahydrocyclopenta[b]furan-3a-yl)acylamide based scaffolds: synthesis and cysteinyl proteinase inhibition
【24h】

Functionalised 2,3-dimethyl-3-aminotetrahydrofuran-4-one and N-(3-oxo-hexahydrocyclopenta[b]furan-3a-yl)acylamide based scaffolds: synthesis and cysteinyl proteinase inhibition

机译:功能化的2,3-二甲基-3-氨基四氢呋喃-4-酮和N-(3-氧代六氢环戊[b]呋喃-3a-基)酰基酰胺基支架:合成和半胱氨酰蛋白酶抑制

获取原文
获取原文并翻译 | 示例
           

摘要

A stereoselective synthesis of functionalised (2R, 3R)-2,3-dimethyl-3-amidotetrahydrofuran-4-one, its (2S,3R)-epimer and (3aR,6aR)-N-(3-oxo-hexahydrocyclopenta[b]furan-3a-yl)acylamide cysteinyl proteinase inhibitors has been developed using Fmoc-protected scaffolds 6-8 in a solid-phase combinatorial strategy. Within these scaffolds, the introduction of an alkyl substituent a to the ketone affords chiral stability to an otherwise configurationally labile molecule. Preparation of scaffolds 6-8 required stereo-selective syntheses of suitably protected α-diazomethylketone intermediates 9-11, derived from appropriately protected α-meth-ylthreonines (2R,3R)-12, (2R, 3S)-13 and a protected analogue of (1R, 2R)-1-amino-2-hydroxycyclopentanecarboxylic acid 14. Application of standard methods for the preparation of amino acid α-diazomethylketones, through treatment of the mixed anhydride or pre-formed acyl fluorides of intermediates 12-14 with diazomethane, proved troublesome giving complex mixtures. However, the desired α-diazomethylketones were isolated and following a lithium chloride/acetic acid promoted insertion reaction provided scaffolds 6-8. Elaboration of 6-8 on the solid phase gave α,β-dimethyl monocyclic ketone based inhibitors 38a-f, 39a,b,d,e,f and bicyclic inhibitors 40a-e that exhibited low micromolar activity against a variety of cysteinyl proteinases.
机译:立体选择性合成功能化的(2R,3R)-2,3-二甲基-3-酰胺基四氢呋喃-4-酮,其(2S,3R)-受体和(3aR,6aR)-N-(3-氧代-六氢环戊五烯[b]使用Fmoc保护的支架6-8以固相组合策略开发了呋喃-3a-基)酰基酰胺半胱氨酸蛋白酶抑制剂。在这些支架中,将烷基取代基α引入酮为手性稳定的分子提供了手性稳定性。支架6-8的制备需要适当保护的α-重氮甲基酮中间体9-11的立体选择性合成,该中间体由适当保护的α-甲基-苏氨酸(2R,3R)-12,(2R,3S)-13和受保护的类似物衍生而来(1R,2R)-1-氨基-2-羟基环戊烷羧酸的制备方法14.通过重氮甲烷处理中间体12-14的混合酸酐或预先形成的酰氟来制备氨基酸α-重氮甲基酮的标准方法的应用,证明给复杂的混合物带来麻烦。然而,分离了所需的α-重氮甲基酮,并在氯化锂/乙酸促进的插入反应之后提供了支架6-8。在固相上精制6-8得到了基于α,β-二甲基单环酮的抑制剂38a-f,39a,b,d,e,f和双环抑制剂40a-e,其对多种半胱氨酸蛋白酶表现出低的微摩尔活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号